Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 4 days ago"This is a new chapter in the history of our company," Novavax CEO John Jacobs told Yahoo Finance in...
Is This a Setback for Moderna?
The Motley Fool via AOL· 14 hours agoModerna is seeking approval for its vaccine in people over age 60 in various countries around the world, including the U.S. Last year, regulators...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 4 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe CDC has also recommended the use of both GSK and Pfizer’s RSV vaccines for older adults. GSK’s...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 1 day agoNovavax will receive $500 million in upfront payments as well as a further $700 million if all...
Pfizer whistleblower shares chilling video: ‘Tired of feeling like I have no hope…but I am NOT...
BizPac Review· 5 days agoA woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant. In addition, she’s published an ominous video declaring ...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 4 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
Fortune· 6 days agoAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when ...
UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Reuters via Yahoo Finance· 5 days agoNovavax on Friday removed doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 vaccines in exchange ...